Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20235331rdf:typepubmed:Citationlld:pubmed
pubmed-article:20235331lifeskim:mentionsumls-concept:C0019196lld:lifeskim
pubmed-article:20235331lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20235331lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:20235331lifeskim:mentionsumls-concept:C0524910lld:lifeskim
pubmed-article:20235331lifeskim:mentionsumls-concept:C0017431lld:lifeskim
pubmed-article:20235331lifeskim:mentionsumls-concept:C0201950lld:lifeskim
pubmed-article:20235331lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:20235331lifeskim:mentionsumls-concept:C0428466lld:lifeskim
pubmed-article:20235331lifeskim:mentionsumls-concept:C0065055lld:lifeskim
pubmed-article:20235331pubmed:issue6lld:pubmed
pubmed-article:20235331pubmed:dateCreated2010-5-31lld:pubmed
pubmed-article:20235331pubmed:abstractTextRecently, genetic polymorphisms occurring in the interferon (IFN)-lambda gene region were associated with response to IFN-based treatment of hepatitis C infection. Both infection with the hepatitis C virus and IFN therapy are associated with decreased serum cholesterol and high cholesterol has been associated with increased likelihood to respond to IFN. We sought to determine if the IFN-lambda gene variant was also associated with serum lipid levels in chronic hepatitis C patients. We compared genotypes of the rs12979860 polymorphism, located proximal to the IL28 gene, with serum lipid and apolipoprotein levels in 746 subjects with chronic hepatitis C virus infection, not currently undergoing treatment, using multivariable analysis of variance. Levels of total cholesterol (P = 6.0 x 10(-4)), apolipoprotein B (P = 1.3 x 10(-6)) and low-density lipoprotein (LDL) cholesterol (P = 8.9 x 10(-10)) were significantly higher in subjects carrying the rs12979860 CC responder genotype compared with those with the CT or TT genotype. Levels of triglycerides (P = 0.03), apolipoprotein A-I (P = 0.06), and apolipoprotein E (P = 0.01) were slightly lower in the rs12979860 CC genotype group, whereas levels of high-density lipoprotein cholesterol (P = 0.78) and apolipoprotein C-III (P = 0.74) did not vary by rs12979860 genotype. CONCLUSION: Our results suggest that low levels of LDL cholesterol in chronic hepatitis C patients may be a marker of host endogenous IFN response to hepatitis C and that subjects with the rs12979860 CC responder genotype may have a lower endogenous IFN response to the virus.lld:pubmed
pubmed-article:20235331pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:languageenglld:pubmed
pubmed-article:20235331pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:citationSubsetIMlld:pubmed
pubmed-article:20235331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20235331pubmed:statusMEDLINElld:pubmed
pubmed-article:20235331pubmed:monthJunlld:pubmed
pubmed-article:20235331pubmed:issn1527-3350lld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:TillmannHans...lld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:McHutchisonJo...lld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:PatelKeyurKlld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:MuirAndrew...lld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:GuytonJohn...lld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:ThompsonAlexa...lld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:GardnerStephe...lld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:McCarthyJeane...lld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:SuchindranSun...lld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:LaoXiang...lld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:RowellJennife...lld:pubmed
pubmed-article:20235331pubmed:authorpubmed-author:LiJosephine...lld:pubmed
pubmed-article:20235331pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20235331pubmed:volume51lld:pubmed
pubmed-article:20235331pubmed:ownerNLMlld:pubmed
pubmed-article:20235331pubmed:authorsCompleteYlld:pubmed
pubmed-article:20235331pubmed:pagination1904-11lld:pubmed
pubmed-article:20235331pubmed:dateRevised2011-7-28lld:pubmed
pubmed-article:20235331pubmed:meshHeadingpubmed-meshheading:20235331...lld:pubmed
pubmed-article:20235331pubmed:meshHeadingpubmed-meshheading:20235331...lld:pubmed
pubmed-article:20235331pubmed:meshHeadingpubmed-meshheading:20235331...lld:pubmed
pubmed-article:20235331pubmed:meshHeadingpubmed-meshheading:20235331...lld:pubmed
pubmed-article:20235331pubmed:meshHeadingpubmed-meshheading:20235331...lld:pubmed
pubmed-article:20235331pubmed:meshHeadingpubmed-meshheading:20235331...lld:pubmed
pubmed-article:20235331pubmed:meshHeadingpubmed-meshheading:20235331...lld:pubmed
pubmed-article:20235331pubmed:meshHeadingpubmed-meshheading:20235331...lld:pubmed
pubmed-article:20235331pubmed:meshHeadingpubmed-meshheading:20235331...lld:pubmed
pubmed-article:20235331pubmed:meshHeadingpubmed-meshheading:20235331...lld:pubmed
pubmed-article:20235331pubmed:meshHeadingpubmed-meshheading:20235331...lld:pubmed
pubmed-article:20235331pubmed:year2010lld:pubmed
pubmed-article:20235331pubmed:articleTitleInterferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.lld:pubmed
pubmed-article:20235331pubmed:affiliationInstitute for Genome Sciences and Policy, Durham, NC 27708, USA.lld:pubmed
More...